NurExone Historical Balance Sheet
| NRX Stock | 0.71 0.01 1.43% |
Trend analysis of NurExone Biologic balance sheet accounts such as Total Stockholder Equity of 179.6 K provides information on NurExone Biologic's total assets, liabilities, and equity, which is the actual value of NurExone Biologic to its prevalent stockholders. By breaking down trends over time using NurExone Biologic balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
NurExone |
About NurExone Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of NurExone Biologic at a specified time, usually calculated after every quarter, six months, or one year. NurExone Biologic Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of NurExone Biologic and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which NurExone currently owns. An asset can also be divided into two categories, current and non-current.
NurExone Biologic Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of NurExone Biologic assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in NurExone Biologic books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on NurExone Biologic balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of NurExone Biologic are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most accounts from NurExone Biologic's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into NurExone Biologic current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NurExone Biologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
| 2010 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 242K | 1.2M | 1.4M | 791.5K | Total Assets | 2.8M | 2.8M | 2.2M | 2.1M |
NurExone Biologic balance sheet Correlations
Click cells to compare fundamentals
NurExone Biologic Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NurExone Stock Analysis
When running NurExone Biologic's price analysis, check to measure NurExone Biologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NurExone Biologic is operating at the current time. Most of NurExone Biologic's value examination focuses on studying past and present price action to predict the probability of NurExone Biologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NurExone Biologic's price. Additionally, you may evaluate how the addition of NurExone Biologic to your portfolios can decrease your overall portfolio volatility.